Enzn stock carl icahn biography company

Submitted by Scott Matusow as part of our contributors program. Carl C. Icahn has been the principal beneficial shareholder of Icahn Enterprises L. The compensation of CEOs is a subject on which Icahn focuses publicly, as he believes that many are grossly overpaid and that their pay has little correlation to stock performance.

Enzn stock carl icahn biography company: Based on ownership reports from SEC

Many times investors follow the lead of Icahn, buying into the businesses he sets his focus upon. One company I like going forward is currently being influenced by Mr. Enzon Pharma is a biotechnology company dedicated to the research and development of innovative therapeutics for cancer patients with high unmet medical needs. Enzon currently has four compounds in human clinical development and multiple novel mRNA antagonists in preclinical research.

Enzon receives royalty revenues from licensing arrangements with other companies related to sales of products developed using its proprietary Customized Linker Technology. For the nine months ended September 30, , royalty revenue remained flat compared to the same period in Enzon combines two things I typically will appreciate with a pharmaceutical company, revenue coming in the door to supplement a diverse pipeline.

This gives me the confidence that the company will not be simply diluting in order to raise money.